Transcript Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013

Tools to Access the Latest Cancer
Statistics
Paul Miller Washington Reporting Fellowships program presentation
April 15, 2013
Surveillance, Epidemiology, and End Results (SEER)
Program: Cancer Registries and Collaborators
SEER area, funded by NCI
SEER/NPCR* area, funded by NCI and CDC
NPCR area, funded by CDC
*NPCR – National Program of Cancer Registries
The SEER Program
 SEER collects data on cancer incidence and survival, calculates
prevalence, and compiles these statistics, plus also reports
mortality data.
 NCI’s Surveillance Research Program (SRP) reports data
collected by SEER in the Cancer Statistics Review and other
publications made available to reporters and the public. It is
usually updated every April 15. This year’s update will cover
the period from 1975-2010
 Data is also available through SEER tools and resources, such as
SEER*Stat software and linked data files. Requests are handprocessed.
Annual Report to the Nation
on the Status of Cancer
• NCI partners on the “The Annual Report to the Nation
on the Status of Cancer” with CDC, the American
Cancer Society, and the North American Association of
Central Cancer Registries.
• The most recent Annual Report to the Nation appeared
in JNCI on Jan. 7, 2013, with a special section on Human
Papilloma Virus (HPV) surveillance.
• The next Annual Report, covering the time period 19752010, should appear early in 2014.
SEER Cancer Stat Fact Sheet
Cancer Stat Fact Sheets provide statistical
summaries for 30 cancer sites, including
for “All Cancer Sites.”
seer.cancer.gov/statfacts/
Cancer Stat Fact Sheet: All Cancer Sites
 For each fact sheet, statistics may
include Incidence & Mortality, Survival,
Lifetime Risk, and Prevalence.
 These are updated annually to coincide
with SEER data release.
Cancer Stat Fact Sheet: All Cancer Sites
SEER Incidence
SEER Incidence
 Incidence is the number of new cases of disease
diagnosed each year.
The “age-adjusted” incidence rate for All Cancer
Sites was 465.2 per 100,000 people per year.
This is based on cases diagnosed in 2005-2009
from 18 SEER geographic areas.
Cancer Stat Fact Sheet: All Cancer Sites
US Mortality
US Mortality
 US mortality is the number of deaths in a certain
group of people in a certain period of time.
The “age-adjusted” death rate for All Cancer Sites
was 178.7 per 100,000 people per year.
This rate is based on patients who died in 20052009 in the United States.
Cancer Stat Fact Sheet: All Cancer Sites
Trends in Rates
Trends in SEER Incidence Rates
 Trends can be evaluated by the annual percent
change (APC).
From 1998 to 2009 the APC for All Cancer Sites
was -0.5. This was a statistically significant
decrease.
Joinpoint analyses are used to evaluate when
changes in the trend occurred with the APC.
Joinpoint Trends in SEER Incidence Rates, 1975-2009
All Cancer Sites
550
Rate per 100,000
500
1992-1995
-2.5
1989-1992
2.8
1998-2009
-0.5*
1995-1998
1.2
450
1975-1989
1.2*
Joinpoint Trend in SEER Cancer Incidence
400
 An asterisk after the APC indicates that the
trend was statistically significant.
350
Negative estimate indicates that cancer
incidence was decreasing in that time period.
~
~
3000
1975
1977
1979
1981
1983
1985
1987
1989
1991
1993
Year
1995
1997
1999
2001
2003
2005
2007
2009
Cancer Stat Fact Sheet: All Cancer Sites
Survival
Survival
These survival statistics are based on 5-year
Relative Survival. Relative survival estimates
the percentage of patients expected to survive
their cancer at a least 5 years after diagnosis.
 The overall 5-year relative survival rate for men
and women was 65.4%.
This is based on cases diagnosed between
2002-2008 from 18 SEER geographic areas.
Cancer Stat Fact Sheet: All Cancer Sites
Lifetime Risk
Lifetime Risk
 Lifetime Risk is an estimate of the percentage of
patients who will be diagnosed with cancer in their
lifetime.
 Based on rates from 2007-2009, 41.2% of men and
women born today will be diagnosed with cancer in
their lifetime.
SEER also calculates the probability of developing
cancer between two age groups. This is available in Fast
Stats.
Cancer Stat Fact Sheet: All Cancer Sites
Prevalence
Prevalence
 Prevalence is the number of people alive that have had
a previous diagnosis of cancer.
 On January 1, 2009, there were 12,553,337 men and
women alive who had a history of cancer of all sites.
Trends in SEER Incidence by
Primary Cancer Site, 2000-2009
Thyroid
Liver & Intrahepatic Bile Duct
Kidney & Renal Pelvis
Melanoma of the Skin
Pancreas
Corpus & Uterus, NOS
Hodgkin Lymphoma
Testis
Non-Hodgkin Lymphoma
Oral Cavity & Pharynx
6.6*
3.7*
2.9*
1.9*
1.0*
0.7*
0.6
0.4*
0.2
0.1
Myeloma
Brain & Other Nervous System
Lung & Bronchus (Female)
Urinary Bladder
All Sites Except Lung & Bronchus
All Cancer Sites
Breast (Female)
Esophagus
Leukemia
Stomach
Ovary
Cervix Uteri
Prostate
Lung & Bronchus (Male)
Larynx
Colon & Rectum
-0.1
-0.2
-0.3
-0.5*
-0.5
-0.6*
-0.7*
-0.7*
-0.9*
-1.2*
-1.6*
-1.9*
-1.9*
-2.0*
-2.4*
-2.4*
-3
-2
-1
0
1
2
3
4
5
6
7
Average Annual Percent Change 2000-2009
* The APC is significantly different from zero (p<.05)
Trends in US Death Rates by
Primary Cancer Site, 2000-2009
Liver & Intrahepatic Bile Duct
Thyroid
Melanoma of the Skin
Pancreas
Corpus & Uterus, NOS
Urinary Bladder
2.4*
1.1*
0.5*
0.4*
0.2
0
Esophagus
-0.5*
-0.6*
-0.7
-0.7*
-0.9*
-1.1*
Brain & Other Nervous System
Testis
Lung & Bronchus (Female)
Kidney & Renal Pelvis
Leukemia
Oral Cavity & Pharynx
All Cancer Sites
-1.4*
-1.5*
-1.5*
-1.6*
-1.7*
-1.8*
All Sites Except Lung & Bronchus
Ovary
Cervix Uteri
Myeloma
Breast (Female)
Hodgkin Lymphoma
Lung & Bronchus (Male)
Larynx
Colon & Rectum
-2.1*
-2.2*
-2.3*
-2.4*
-3.0*
-3.0*
-3.1*
Non-Hodgkin Lymphoma
Stomach
Prostate
-3.5*
-4
-3
-2
-1
0
1
2
3
Average Annual Percent Change 2000-2009
* The APC is significantly different from zero (p<.05)
SEER Web Sites
• SEER Home Page (http://seer.cancer.gov/)
• Cancer Statistics (http://seer.cancer.gov/statistics/)
– Fact Sheets
– Cancer Statistics Review (CSR)
– State Cancer Profiles
• Access to SEER Datasets and NCI Software to analyze
data (http://seer.cancer.gov/resources/)
What is State Cancer Profiles?
 Statistics for prioritizing
cancer control activities
 National, state, and local level data
 Collaboration
 CDC’s National Program of Cancer Registries
(NPCR)
 NCI’s Surveillance, Epidemiology and End
Results Registries (SEER)
Available Data
 Cancer incidence, mortality data and
prevalence data
 Latest data years currently available
 2009 NCI SEER incidence (2010 coming
soon)
 2009 CDC NPCR incidence
 2009 NCHS mortality
 About 20 different cancer sites
 Screening and risk factor data
State Cancer Profiles Usage
Resource for:
 Priority setting; planning
 Implementing and assessing cancer control projects
 Exposing health disparities
 Comparing state cancer data with other states
 Reviewing trends in cancer
 Presentations, reports, proposals, training
Quick Profiles
Support
Data
Death Rate/Trend Comparison by Cancer
SCP: Screening and Risk Factors
Mammography by State
Mammography by Small Area Estimates
Demographic Data
Population: Age Groups
Population: Race Groups
Education
Income
Housing
Urban/Rural
Workforce: Unemployed
Poverty
Persons below Poverty
Coming Soon to State Cancer Profiles
 Home Page
 HINTS (Health Interview National Trends Survey)
 Demographic data
 Small Area Health Insurance Estimates
Questions
Please visit:
www.cancer.gov